The Whole C-Suite Is Buying $OBK Shares

Every day, we sift through the filings to spot where the real conviction lies – cutting through the noise to highlight the most meaningful insider moves.

📌 Origin Bancorp $OBK – Multiple insiders, including the CEO, CFO, CAO, and CLO, jointly filed for $729,000 in Form 4s.
 
It’s not every day you see a coordinated insider cluster buy like this – a rare show of unified conviction across the executive suite and a strong vote of confidence for the Louisiana-based regional bank.

📌 Eastern Bankshares $EBC – CFO James Fitzgerald added $340,000 in shares.
 
Eastern continues to draw steady insider interest, with its president, CEO, and now CFO buying in recent weeks – a constructive signal as the regional bank hurdles continue. 

Here’s The Hot Corner, with data from October 29, 2025:

Click the table to enlarge it.

📌 Compass Therapeutics $CMPX – Biotechnology Value Fund initiated a 5.10% stake.
 
BVF, the biotech specialist run by Mark Lampert, is known for concentrated, high-conviction bets around clinical catalysts. Their entry often coincides with meaningful scientific readouts.

📌 Rep. Lisa McClain – Disclosed fresh trades across multiple speculative growth names, including Rigetti $RGTI, BigBear.ai $BBAI, and NuScale Power $SMR, totaling up to $200,000 in exposure.